No results found

Check the spelling or try searching for a more general term.

Hawaiian Eye 2019

Hawaiian Eye 2019

Ellex invites you to join us in Waikoloa for Hawaiian Eye 2019, 20-25 January. Visit the Ellex Exhibit #101-102 to discuss the role of the iTrack™ Surgical System as an adjunctive MIGS procedure, along with the role of Ellex’s proprietary Reflex Technology™ in the treatment of symptomatic floater patients. A highlight at the Hawaiian Eye 2019 will be Ellex’s breakthrough 2RT® Retinal Rejuvenation Therapy for early AMD – the first and only clinically proven laser treatment for early AMD.

2RT® Retinal Rejuvenation

#AMDelay

Retinal Rejuvenation Therapy or 2RT® offers the potential to intervene earlier in the treatment of AMD to delay the rate of progression to late-stage disease. The first and only clinically proven laser treatment to delay progression to late-stage AMD, 2RT® features unique Nanopix Technology™ to stimulate a biological healing process that results in cellular rejuvenation, renewing the entire transport mechanism of the retina and improving the hydraulic conductivity of Bruch’s membrane. This rejuvenation process preserves or improves functional vision and reduces disease progression — without causing collateral damage to the overlying photoreceptor rods and cones of the retina.

Lead Trial: 2RT for early AMD

Join our team of 2RT® clinical specialists at the Ellex Exhibit #101-102 to discuss the clinical application of 2RT® in cases of intermediate AMD., Earlier this year, the 36-month results of the multi-center randomized “Laser Intervention for Early Age-Related Macular Degeneration” (LEAD) clinical trial, demonstrated that, in patients who did not have coexistent reticular pseudodrusen (RPD) (76% of patients enrolled), 2RT® achieved a clinically meaningful 77% reduction in the rate of progression from intermediate AMD to late AMD.

The major difference between 2RT nanopulse laser therapy and conventional lasers is the difference in the responses in the patient. With a conventional laser, you will always get some collateral damage to the light sensitive cells. With 2RT being this disruptive mechanism, we have no collateral damage and therefore we get the therapeutic effect with none of the collateral effects of damage to the light sensitive cells.

Prof. John Marshall
Emeritus Professor of Ophthalmology, King’s College London
Honorary distinguished Professor in Visual Science, University of Cardiff

ABiC™ WITH THE iTRACK™ SURGICAL SYSTEM

MIGS Meet the Expert / Wet Lab

Join ABIC™ expert Mahmoud A. Khaimi, MD(USA) at the Ellex Exhibit #101-102 to discuss his clinical tips and surgical pearls for ABiC™, the next step in canal-based MIGS. Intuitive and efficient, ABiC™ can be performed as a stand-alone procedure, or it can be combined with cataract surgery. ABiC™ can also be used in conjunction with other MIGS devices or treatments — and, as an atraumatic procedure, it does not preclude future treatment options.

Each session will incorporate Wet Labs featuring the Ellex iTrack™ Surgical System. 

Faculty

Mahmoud A. Khaimi
MD (USA)

SUNDAY, 20 JANUARY
9:00 – 9:30am

MONDAY, 21 JANUARY
Session 1:
9:00 – 9:30am

Session 2:
10:30 – 11:00am

Register your interest

Note: these sessions are not affiliated with the official program of Hawaiian Eye 2019.

I have been a practicing glaucoma specialist for over 10 years. The introduction of ABiC has completely changed my glaucoma treatment paradigm. Not only has ABiC proven itself to be highly effective in lowering IOP and reducing medication dependence, it also offers an excellent safety profile. There is no manipulation of the conjunctiva, and the post-op recovery resembles that of cataract surgery.

Mahmoud A. Khaimi, MD
Dean McGee Eye Institute, University Of Oklahoma


MIGS Workshop

Dr. Mahmoud A. Khaimi (USA) will host a hands-on Workshop during Hawaiian Eye 2019 to discuss ABiC™ as a comprehensive minimally invasive glaucoma surgery (MIGS) procedure that flushes out the natural outflow channels without damaging tissue, restoring the eye’s natural outflow drainage system.

Instructor

Mahmoud A. Khaimi
MD (USA)

MONDAY, 21 JANUARY
2:00pm – 4:00pm
Hilton Waikoloa Village
Room: Waikoloa 3

Register your interest Download the invitation

Note: these sessions are not affiliated with the official program of Hawaiian Eye 2019.


Ellex iTrack Physician Dinner

Join your colleagues and leading ABiC™ expert Mahmoud Khaimi, MD (USA), Dean McGee Eye Institute, for an intimate discussion over dinner to address the role of ABiC™, including its adjunctive role with other MIGS options. The synergies between ABiC™ and SLT will also be discussed.

Speakers

Mahmoud A. Khaimi
MD (USA)

DATE: Sunday, 20 January
TIME:
5:30pm
VENUE:
Napua at Mauna Lani Beach Club
1292 S. Kaniku Drive #68
Waimea, HI 96743

Note: these sessions are not affiliated with the official program of Hawaiian Eye 2019.

Proactive Glaucoma Care

Ellex is at the vanguard of working with physicians to transform outcomes and quality of life for patients with glaucoma. Our leading edge SLT Selective Light Therapy and ABiC™ – our restorative solution for minimally invasive glaucoma surgery, performed with the iTrack™ surgical system – offer the ability to intervene earlier in the treatment of glaucoma, and to treat across the full spectrum of the disease, and thereby enable significant numbers of patients to minimize or obviate the need for medications to control their glaucoma.

At Ellex, we're proud to be helping to shift the paradigm towards proactive glaucoma care. Visit the Ellex exhibit #101-102 to learn more.

My treatment paradigm is to go to SLT as primary therapy, and then use a MIGS procedure like ABiC with the iTrack after that. If the disease progresses, my next steps would be perhaps SLT again, and then maybe some other MIGS, pushing back filtering and tube surgeries to later stages. In this paradigm, medication has fallen to an adjunct in between those treatment stages.

Mahmoud A. Khaimi, MD
Dean McGee Eye Institute, University Of Oklahoma

Floater Management

Meet the LFT Expert

Join us at the Ellex Exhibit #101-102 to meet leading LFT expert Inder Paul Singh, MD (USA), during a series of “Meet the Expert” sessions. Having performed more than 4000 LFT procedures using Ellex’s proprietary Reflex Technology™, Dr. Singh is an expert in the treatment of symptomatic floater patients. Visit the Ellex Exhibit daily to hear his surgical pearls and clinical tips, including the benefits of Reflex Technology™, for laser-based floater treatment.

Faculty

Paul Singh
MD (USA)

SUNDAY, 20 JANUARY
9:00am

MONDAY, 21 JANUARY
SESSION 1: 9:00am
SESSION 2: 10:30am

TUESDAY, 22 JANUARY
SESSION 1: 9:00am
SESSION 2: 10:30am

Register your interest

Note: this event is not affiliated with the official program of the Hawaiian Eye 2019.

I adopted laser floater treatment for the symptomatic floater patients just over three years ago. More than 4,000 procedures later, I have been astounded by the positive effect it has had on my patients. I now also fully appreciate the negative impact floaters can have on patients’ quality of life. When looking at the results in my own clinic, more than 90% of patients indicate that they are satisfied with their improvement in daily visual functioning as a result of undergoing the procedure.

Inder Paul Singh, MD (USA)
Eye Centres of Racine and Kenosha, USA


LFT Workshop

Dr. Inder Paul Singh (USA) will host a hands-on LFT Workshop during Hawaiian Eye 2019 to address practical tips and treatment pearls for the treatment of symptomatic floater patients with Ellex's proprietary Reflex Technology. Dr. Singh recently hosted an Instructional Course for LFT at the 2018 meeting of the AAO.

Instructor

Paul Singh
MD (USA)

Tuesday, 22 January
2:00pm – 4:00pm
Hilton Waikoloa Village
Room: Waikoloa 2

Register your interest Download the invitation

Note: this event is not affiliated with the official program of the Hawaiian Eye 2019.

LFT from Ellex

Ellex was the first company to pioneer a laser designed specifically for the treatment of floaters. Our Reflex Technology™ platform features True Coaxial Illumination™ (TCI), on and off-axis modes, a precise aiming beam and a superior energy beam profile. It’s an approach that maximizes focusing accuracy and provides a safe and highly effective tool for the treatment of vitreous opacities.

Featuring coaxial (on) and off-axis illumination, Reflex Technology allows for clear visualization of the internal eye from the cornea all the way to the retina, and as such, provides much-needed spatial context for procedures like laser floater treatment.

Inder Paul Singh, MD (USA)
The Eye Centers of Rachine and Kenosha, USA

Introducing Eye Prime: the next generation ultrasound solution

Featuring the industry’s first Six-Ring Phased Array Annular Technology, Eye Prime™ is a breakthrough that transforms your view of even the finest ocular structures, enabling you to view, diagnose and treat more accurately and more efficiently than ever before. Eye Prime™ transmits and receives ultrasound waves from six concentric transducers, which can be individually pulsed. The transmitted beam from each transducer can be focused through a wide range of depths in 1mm increments and thereby enables you to focus anywhere in the posterior segment.

Visit the Ellex Exhibit #101-102 at Hawaiian Eye 2019 to preview the new Eye Prime™ ultrasound system. Our team of expert ecographers will be on-hand daily to demonstrate this breakthrough technology.

Floater Visualization
Eye Prime™, matched with Ellex’s proprietary Reflex Technology™, represents the perfect partnership for the visualization and treatment of symptomatic floaters. In Eye Prime’s 12MHz mode the retina, optic nerve and extraocular muscles are presented in superior detail.

Eye Prime is not approved for sale
in the USA. FDA 510(k) pending

Ellex is the manufacturer of 2RT®. It has been approved for the indications Clinically Significant Macular Edema (CSME) and in patients with early Age-Related Macular Degeneration (AMD) where it can produce bilateral improvements in macular appearance and function under CE marking. Ellex does not accept any responsibility for use of the system outside of these indications. The material presented herein may include the views or recommendations of third parties and does not necessarily reflect the views of Ellex Medical Pty Ltd.

2RT® has a CE Mark (Conformité Européene) for treatment in patients with early AMD where it can produce bilateral improvements in macular appearance and function.

2RT® has a CE Mark (Conformité Européene) and US Food and Drug Administration (FDA) (510k) Market release for the treatment of Clinically Significant Macula Edema (CSME).

Welcome to Ellex Global. Continue to Ellex USA at ellex.comus/
Let's go!
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More